MX2016011801A - Crema de estradiol de dosis baja. - Google Patents

Crema de estradiol de dosis baja.

Info

Publication number
MX2016011801A
MX2016011801A MX2016011801A MX2016011801A MX2016011801A MX 2016011801 A MX2016011801 A MX 2016011801A MX 2016011801 A MX2016011801 A MX 2016011801A MX 2016011801 A MX2016011801 A MX 2016011801A MX 2016011801 A MX2016011801 A MX 2016011801A
Authority
MX
Mexico
Prior art keywords
low
dose estradiol
estradiol cream
cream
dose
Prior art date
Application number
MX2016011801A
Other languages
English (en)
Inventor
M Devries Tina
Ellman Herman
Original Assignee
Warner Chilcott Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Chilcott Co Llc filed Critical Warner Chilcott Co Llc
Publication of MX2016011801A publication Critical patent/MX2016011801A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describe una crema de estradiol de dosis baja para la administración vaginal, que es segura y clínicamente efectiva para tratar los síntomas de la menopausia, y un kit que comprende la crema de estradiol de baja dosis y un aplicador. Se proporciona también un método de tratamiento de los síntomas de atrofia vulvar y/o vaginal asociadas con menopausia, que incluye el paso de administrar vaginalmente la crema de estradiol de baja dosis a una mujer en necesidad de la misma.
MX2016011801A 2014-03-12 2015-03-12 Crema de estradiol de dosis baja. MX2016011801A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461952045P 2014-03-12 2014-03-12
PCT/US2015/020068 WO2015138668A1 (en) 2014-03-12 2015-03-12 Low-dose estradiol cream

Publications (1)

Publication Number Publication Date
MX2016011801A true MX2016011801A (es) 2017-07-14

Family

ID=52785156

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016011801A MX2016011801A (es) 2014-03-12 2015-03-12 Crema de estradiol de dosis baja.

Country Status (6)

Country Link
US (1) US20150258117A1 (es)
EP (1) EP3116474A1 (es)
AU (2) AU2015229421B2 (es)
CA (1) CA2942345C (es)
MX (1) MX2016011801A (es)
WO (1) WO2015138668A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2495330A1 (en) * 2002-08-28 2004-03-11 Robert Casper Estrogen replacement regimen
MXPA06007852A (es) 2004-01-15 2007-01-31 Warner Chilcott Co Inc Profarmacos di-esteroidales de estradiol.
WO2006127057A1 (en) * 2005-05-24 2006-11-30 Lyle Corporate Drvelopment, Inc. Non-systematic vaginal administration of estrogen and an androgen for the treatment of sexual dysfunction
CA2612415A1 (en) 2005-06-16 2006-12-28 Warner Chilcott Company, Inc. Estrogen compositions for vaginal administration
CN101232869B (zh) 2005-06-16 2016-03-02 沃纳奇尔科特有限责任公司 局部给药的凝胶组合物
US10016442B2 (en) 2005-06-16 2018-07-10 Allergan Pharmaceuticals International Limited Estrogen compositions for vaginal administration
AR056453A1 (es) * 2005-08-12 2007-10-10 Drug Tech Corp Composiciones con estrogeno y metodos terapeuticos para su uso
EP2174650A1 (en) * 2008-10-08 2010-04-14 Polichem SA Modified release emulsions for application to skin or vaginal mucosa
WO2013130535A1 (en) * 2012-02-27 2013-09-06 Newgen Biopharma Corporation Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same

Also Published As

Publication number Publication date
AU2020203415A1 (en) 2020-06-11
AU2015229421A1 (en) 2016-09-29
CA2942345C (en) 2020-12-01
AU2015229421B2 (en) 2020-06-04
WO2015138668A1 (en) 2015-09-17
CA2942345A1 (en) 2015-09-17
EP3116474A1 (en) 2017-01-18
US20150258117A1 (en) 2015-09-17

Similar Documents

Publication Publication Date Title
CL2018000706A1 (es) Derivados de pirazolopirimidina como inhibidores btk para el tratamiento del cancer.
PH12016501965A1 (en) S1p modulator immediate release dosage regimen
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
IN2014MU00303A (es)
PH12018502161A1 (en) Methods of treatment for cholestatic and fibrotic diseases
MX2016014913A (es) Dispositivo y formulacion para el tratamiento topico de dolor que afecta a la zona vulvar del organo genital humano femenino.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
NZ745187A (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2016005092A (es) Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos.
MX2016008027A (es) Uso de laquinimod para retrasar la evolucion de la enfermedad de huntington.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MY172530A (en) Method for treating gynecological diseases
MX2016011801A (es) Crema de estradiol de dosis baja.
MY198811A (en) Use of fenugreek extract to enhance psychological, somatic and sexual conditions in aging males
MA39009A (fr) Compositions pharmaceutiques comprenant un agent actif
BR112018011483A2 (pt) métodos e composições farmacêuticas com estradiol vaginalmente inserido
MX2018008196A (es) Tratamiento para cancer de mama usando una combinacion de una formulacion liposomal cationica de taxano, una formulacion no liposomal de taxano y un agente activo adicional.
NZ725354A (en) Transdermal formulations of pergolide and uses thereof
MX2022002614A (es) El uso de un pesario que comprende una capsula que contiene estradiol y un agente solubilizante para el tratamiento de la atrofia vulvovaginal.
UA95709U (uk) Спосіб профілактики акушерських та перинатальних ускладнень і покращення нейропсихологічного статусу у вагітних із посткомоційним синдромом
UA97073U (uk) Спосіб інтегрованого лікування дуальної патологічної залежності від алкоголю та аралієвих стимуляторів
UA98498U (ru) Способ коррекции климактерических нарушений у женщин перименопаузального и постменопаузального возраста
UA82250U (ru) Способ лечения больных с неалкогольной жировой болезнью печени
UA100902U (uk) Спосіб лікування мікрогландулярної гіперплазії шийки матки у жінок із порушеннями вегетативного гомеостазу